Research Opportunity – APSHO

Are you a patient with Indolent Systemic Mastocytosis (ISM)?

The Advanced Practitioner Society for Hematology and Oncology (APSHO) and Blueprint Medicines are conducting a survey to learn more about the unique perspective of patients with ISM.

If you would like to participate in the survey, please CLICK HERE.